Tingting Shi

Ms. Tingting Shi


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2021 in Tissue and Cell
Verified
Journal Article
Closed access
BCBoning Cheng
Boning Cheng
JJJianhong Jin
Jianhong Jin
DLDianlei Liu
Dianlei Liu
TSTingting Shi
Tingting Shi
XFXiaoqing Fu
Xiaoqing Fu
RWRui Wu
Rui Wu

29 September 2025 in Turkish Journal of Gastroenterology
Verified
Journal Article
Open access
XZXi Zou
Xi Zou
YKYunling Ke
Yunling Ke
YSYidan Shao
Yidan Shao
SLShourong Liu
Shourong Liu
TSTingting Shi
Tingting Shi
Liver fibrosis is a key intermediate stage in the progression of chronic liver disease to end-stage liver cirrhosis. Mortality rises exponentially once it reaches decompensated liver disease. In a healthy liver microenvironment, hepatocytes, Kupffer cells, hepatic stellate cells (HSCs), liver sinusoidal endothelial cells, and other cells interact with extracellular matrix (ECM) to maintain cell stability and liver function. Different types of liver injury (such as viral hepatitis and alcoholic liver injury) can cause liver fibrosis. Liver injury signals activate Kupffer cells and recruit immune cells, leading to liver inflammation. This inflammation, together with liver injury, stimulates the activation of HSCs. Activated HSCs migrate to injury sites and secrete ECM. The ECM increase and stiffening contribute to fibrosis. Microenvironment changes alter cell phenotypesperpetuating HSC activation. This article explores liver fibrosis mechanisms, reviews cellular and microenvironmental changes, summarizes fibrosis characteristics, and provides insights for clinical treatment. Cite this article as: Zou X, Ke Y, Shao Y, Liu S, Shi T. Liver fibrosis: interactions between cells and microenvironments. Turk J Gastroenterol. 2025;36(11):711-722.

1 January 2021 in Canadian Journal of Gastroenterology and Hepatology
Verified
Journal Article
Open access
PDF file
TSTingting Shi
Tingting Shi
LYLiping Yu
Liping Yu
RZRanxiao Zhuang
Ranxiao Zhuang
JXJianjun Xi
Jianjun Xi
RHRuoyu He
Ruoyu He
XYXingxin Yang
Xingxin Yang
Metabolic associated fatty liver disease (MAFLD) is a multifactorial systemic disorder that occurs in the absence of excessive alcohol consumption. The disease is characterized by fatty degeneration and fat accumulation in liver parenchymal cells, the incidence of which is increasing annually, particularly in younger adults. MAFLD is caused by genetic and metabolism related disorders, of which mitochondrial dysfunction is the major contributor. Natural products can relieve MAFLD through restoring mitochondrial function. In this article, we describe the relationship between mitochondria and MAFLD and discuss the beneficial effects of natural products as a future anti‐MAFLD strategy. Significance Statement. We herein propose that the development of mitochondrial regulators/nutrients from natural products can remedy mitochondrial dysfunction which represents an attractive strategy for the treatment of MAFLD. Furthermore, the mitochondrial regulation of natural products can provide new insight into the underlying mechanisms of action of natural products used for future MAFLD therapeutics.

1 January 2024 in Journal of Chemistry
Verified
Journal Article
Open access
TSTingting Shi
Tingting Shi
JXJianjun Xi
Jianjun Xi
YSYidan Shao
Yidan Shao
QTQiao Tong
Qiao Tong
XZXi Zou
Xi Zou
XGXiaoya Gao
Xiaoya Gao
Pharmaceutical contaminants are causing great attention for the public people, urgently requiring to be eliminated from the environment. Herein, commercial pharmaceutical carbamazepine was chosen as a model to be degraded by a heterogeneous Fenton system using natural pyrite as catalyst. The catalyst was characterized by X‐ray diffraction apparatus, high‐resolution transmission electron microscopy, and X‐ray photoelectron spectroscopy. The elements composition and chemical states of pyrite changed significantly after the Fenton reaction, which promoted the production of active species in the electron transfer process. The degradation efficiency of carbamazepine (2.5 mg/L) can reach 99.71% after 30 min with 0.3 g/L of pyrite and 5 mM of H2O2, respectively. The reaction system was suitable for a wide range of pH (3–9). The environmental adaptability examination of pyrite showed that humic acid (HA) had inhibitory effects on the degradation of carbamazepine. While the changes of degradation efficiency of carbamazepine were inconspicuous in the presence of and , indicating strong anti‐interference to environment common anions. Free‐radical capturers suggested that hydroxyl radical (∙OH), superoxide radical (), and singlet oxygen (1O2) participated in the degradation of carbamazepine. This research has offered a new strategy of “treating wastes with wastes” to use pyrite to remove emerging pollutants.

1 January 2025 in Canadian Journal of Gastroenterology and Hepatology
Verified
Journal Article
Open access
XZXi Zou
Xi Zou
WCWei Chen
Wei Chen
YSYidan Shao
Yidan Shao
TSTingting Shi
Tingting Shi
YKYunling Ke
Yunling Ke
Objective: Investigating the antialcoholic liver injury properties of Rabdosia rubescens and its effect on the expression of CYP7A1 and levels of autophagy. Materials and Methods: Male C57BL/6 mice were randomly divided into three groups, namely, the control group (Lieber–DeCarli standard diet), model group (Lieber–DeCarli ethanol diet), and treatment group ( Rabdosia rubescens at concentrations of 50 mg/kg, 100 mg/kg, and 200 mg/kg). The mice were fed their respective diets for 10 days, with the treatment group receiving the corresponding concentration of Rabdosia rubescens . On the 11th day, all the mice except those in the control group were given 30% EtOH. Nine hours later, the mice were sacrificed and their blood serum and liver tissue were collected for analysis. The effect of Rabdosia rubescens on alcohol‐induced liver damage was evaluated by testing serum biochemical indicators, liver bile acid content, liver tissue histopathological changes, liver LC3 and p62 immunohistochemical staining, liver inflammatory factors, and CYP7A1, SREBP, FAS, LC3, Beclin‐1, ATG7, and p62 expressions. Results: Compared with the model group, Rabdosia rubescens was found to significantly reduce the levels of ALT, AST, TG, TC, and TBA in the serum of mice with alcoholic liver injury ( p < 0.05 or p < 0.01). Rabdosia rubescens was found to significantly reduce the level of apoptosis in H&E‐stained liver tissue sections. Rabdosia rubescens also significantly reduced the levels of TNF‐α and IL‐1β in the livers of mice ( p < 0.001). Rabdosia rubescens was found to induce the expression of LC3, Beclin‐1, and ATG7 proteins and mRNA, while inhibiting the expression of CYP7A1, SREBP, FAS, and p62 proteins and mRNA ( p < 0.05 or p < 0.01). Conclusion: Rabdosia rubescens has been shown to relieve alcohol‐induced liver damage in mice by reducing levels of CYP7A1, alleviating cholestasis and reducing inflammation. It can also reduce alcohol‐induced liver damage by decreasing fat synthesis and inducing autophagy.

29 September 2025 in Turkish Journal of Gastroenterology
Verified
Journal Article
Open access
XZXi Zou
Xi Zou
YKYunling Ke
Yunling Ke
YSYidan Shao
Yidan Shao
SLShourong Liu
Shourong Liu
TSTingting Shi
Tingting Shi
Liver fibrosis is a key intermediate stage in the progression of chronic liver disease to end-stage liver cirrhosis. Mortality rises expo nentially once it reaches decompensated liver disease. In a healthy liver microenvironment, hepatocytes, Kupffer cells, hepatic stellate cells (HSCs), liver sinusoidal endothelial cells, and other cells interact with extracellular matrix (ECM) to maintain cell stability and liver function. Different types of liver injury (such as viral hepatitis and alcoholic liver injury) can cause liver fibrosis. Liver injury signals acti vate Kupffer cells and recruit immune cells, leading to liver inflammation. This inflammation, together with liver injury, stimulates the activation of HSCs. Activated HSCs migrate to injury sites and secrete ECM. The ECM increase and stiffening contribute to fibrosis. Microenvironment changes alter cell phenotypes, perpetuating HSC activation. This article explores liver fibrosis mechanisms, reviews cellular and microenvironmental changes, summarizes fibrosis characteristics, and provides insights for clinical treatment. Cite this article as: Zou X, Ke Y, Shao Y, Liu S, Shi T. Liver fibrosis: interactions between cells and microenvironments. Turk J Gastroenterol. Published online September 29, 2025. doi:10.5152/tjg.2025.25313.